E&G Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,907
| Closed | -$343K | – | 195 |
|
|
2023
Q3 | $343K | Hold |
4,907
| – | – | 0.13% | 140 |
|
|
2023
Q2 | $339K | Buy |
4,907
+15
| +0.3% | +$1.07K | 0.12% | 145 |
|
|
2023
Q1 | $364K | Buy |
4,892
+5
| +0.1% | +$419 | 0.13% | 137 |
|
|
2022
Q4 | $455K | Buy |
4,887
+10
| +0.2% | +$965 | 0.17% | 121 |
|
|
2022
Q3 | $465K | Sell |
4,877
-500
| -9% | -$49.5K | 0.17% | 117 |
|
|
2022
Q2 | $498K | Buy |
5,377
+600
| +13% | +$58.6K | 0.17% | 122 |
|
|
2022
Q1 | $483K | Hold |
4,777
| – | – | 0.13% | 130 |
|
|
2021
Q4 | $493K | Sell |
4,777
-400
| -8% | -$37K | 0.12% | 136 |
|
|
2021
Q3 | $439K | Buy |
+5,177
| New | +$434K | 0.12% | 141 |
|
|
2021
Q2 | – | Sell |
-4,677
| Closed | -$383K | – | 145 |
|
|
2021
Q1 | $352K | Hold |
4,677
| – | – | 0.1% | 150 |
|
|
2020
Q4 | $319K | Sell |
4,677
-100
| -2% | -$6.5K | 0.1% | 153 |
|
|
2020
Q3 | $279K | Sell |
4,777
-44
| -0.9% | -$2.74K | 0.1% | 154 |
|
|
2020
Q2 | $313K | Hold |
4,821
| – | – | 0.12% | 139 |
|
|
2020
Q1 | $286K | Sell |
4,821
-250
| -5% | -$16.7K | 0.14% | 126 |
|
|
2019
Q4 | $377K | Hold |
5,071
| – | – | 0.14% | 141 |
|
|
2019
Q3 | $320K | Sell |
5,071
-1,000
| -16% | -$59.3K | 0.13% | 147 |
|
|
2019
Q2 | $331K | Buy |
6,071
+1,000
| +20% | +$53.9K | 0.14% | 142 |
|
|
2019
Q1 | $273K | Sell |
5,071
-2,100
| -29% | -$130K | 0.12% | 160 |
|
|
2018
Q4 | $470K | Sell |
7,171
-200
| -3% | -$14.9K | 0.21% | 124 |
|
|
2018
Q3 | $580K | Sell |
7,371
-500
| -6% | -$35.7K | 0.22% | 117 |
|
|
2018
Q2 | $506K | Hold |
7,871
| – | – | 0.21% | 114 |
|
|
2018
Q1 | $490K | Buy |
7,871
+1,100
| +16% | +$78.9K | 0.21% | 111 |
|
|
2017
Q4 | $491K | Buy |
6,771
+1,600
| +31% | +$116K | 0.21% | 105 |
|
|
2017
Q3 | $421K | Sell |
5,171
-2,670
| -34% | -$211K | 0.19% | 106 |
|
|
2017
Q2 | $631K | Sell |
7,841
-150
| -2% | -$11.8K | 0.3% | 71 |
|
|
2017
Q1 | $627K | Buy |
7,991
+100
| +1% | +$7.98K | 0.32% | 75 |
|
|
2016
Q4 | $623K | Sell |
7,891
-3,200
| -29% | -$259K | 0.37% | 66 |
|
|
2016
Q3 | $987K | Sell |
11,091
-100
| -0.9% | -$9.44K | 0.58% | 38 |
|
|
2016
Q2 | $1.07M | Buy |
11,191
+21
| +0.2% | +$2.09K | 0.65% | 34 |
|
|
2016
Q1 | $1.16M | Buy |
11,170
+1,070
| +11% | +$104K | 0.76% | 32 |
|
|
2015
Q4 | $987K | Buy |
10,100
+5,200
| +106% | +$509K | 0.59% | 43 |
|
|
2015
Q3 | $473K | Buy |
+4,900
| New | +$515K | 0.3% | 65 |
|
Other funds holding CVS
E&G Advisors's CVS Position: Q4 2023 in Review
E&G Advisors sold out of CVS Health (CVS) in Q4 2023, closing a stake of 4,907 shares — an estimated $343K sold.
E&G Advisors first reported a position in CVS in Q3 2015 and held it in 32 quarters. The position peaked at $1.16M in Q1 2016. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.
- E&G Advisors reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
- E&G Advisors sold 4,907 CVS Health shares in Q4 2023, an estimated $343K.
- E&G Advisors first reported a position in CVS Health in Q3 2015 and held it in 32 quarters.
- E&G Advisors's CVS Health position peaked at $1.16M in Q1 2016.
- 2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.
Based on E&G Advisors's 13F filing for Q4 2023, filed 25 Jan 2024.